Own the gold standard ✨ in financial data & analytics
fair value · 20 million securities worldwide · 50 year history · 10 year estimates · leading business news

Subscribe for $2
Overview
Profile

Chemours stock

CC
US1638511089
A14RPH

Price

19.71
Today +/-
-0.55
Today %
-3.05 %
P

Chemours stock price

%
Weekly
Details

Price

Overview

The Quote Chart provides detailed and dynamic insights into the Chemours stock's performance, showcasing daily, weekly, or monthly aggregated quotes. Users can switch between different time frames to analyze the stock's progression meticulously and make informed investment decisions.

Intraday Feature

The intraday feature provides real-time data, allowing investors to view the Chemours stock’s price fluctuations within the trading day, facilitating timely and strategic investment decisions.

Total Return and Relative Price Change

View the total return of the Chemours stock to gauge its profitability over time. The relative price change, based on the first quote available in the selected timeframe, offers insights into the stock’s performance, assisting in evaluating its investment potential.

Interpretation and Investment

Utilize the comprehensive data presented in the Quote Chart to analyze Chemours's market trends, price movements, and potential returns. Make informed investment choices by comparing different time frames and evaluating intraday data for optimized portfolio management.

Chemours Stock Price History

DateChemours Price
10/1/202419.71 undefined
9/30/202420.32 undefined
9/27/202420.72 undefined
9/26/202420.80 undefined
9/25/202418.69 undefined
9/24/202419.55 undefined
9/23/202418.77 undefined
9/20/202418.70 undefined
9/19/202419.24 undefined
9/18/202418.48 undefined
9/17/202418.48 undefined
9/16/202418.04 undefined
9/13/202417.95 undefined
9/12/202417.15 undefined
9/11/202417.02 undefined
9/10/202416.79 undefined
9/9/202417.10 undefined
9/6/202417.47 undefined
9/5/202418.50 undefined
9/4/202418.53 undefined
9/3/202418.63 undefined

Chemours Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

Understanding Revenue, EBIT, and Income

Gain insights into Chemours, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Chemours from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Chemours’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Chemours. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Chemours’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Chemours’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Chemours’s growth potential.

Chemours Revenue, EBIT and net profit per share

DateChemours RevenueChemours EBITChemours Net Income
2026e6.55 B undefined921.62 M undefined520.63 M undefined
2025e6.25 B undefined802.45 M undefined397.98 M undefined
2024e5.88 B undefined573.54 M undefined198.39 M undefined
20236.03 B undefined-92 M undefined-238 M undefined
20226.79 B undefined788 M undefined578 M undefined
20216.35 B undefined682 M undefined608 M undefined
20204.97 B undefined447 M undefined219 M undefined
20195.53 B undefined435 M undefined-52 M undefined
20186.64 B undefined1.3 B undefined995 M undefined
20176.18 B undefined1.04 B undefined746 M undefined
20165.4 B undefined411 M undefined7 M undefined
20155.72 B undefined226 M undefined-90 M undefined
20146.43 B undefined532 M undefined400 M undefined
20136.86 B undefined532 M undefined423 M undefined
20127.37 B undefined1.46 B undefined1.06 B undefined
20117.97 B undefined1.73 B undefined1.43 B undefined

Chemours Income Statement, Balance Sheet, Cash Flow Statement

  • Simple

  • Expanded

  • Income Statement

  • Balance Sheet

  • Cashflow

 
REVENUE (B)REVENUE GROWTH (%)GROSS MARGIN (%)GROSS INCOME (B)EBIT (B)EBIT MARGIN (%)NET INCOME (B)NET INCOME GROWTH (%)DIV. ()DIV. GROWTH (%)SHARES (M)DOCUMENTS
20112012201320142015201620172018201920202021202220232024e2025e2026e
7.977.376.866.435.725.46.186.645.534.976.356.796.035.886.256.55
--7.61-6.87-6.23-11.12-5.5414.507.36-16.75-10.0827.697.08-11.29-2.416.314.75
32.5831.9221.3421.1416.7020.4328.2229.6919.2421.4721.7723.7921.67---
2.62.351.461.360.961.11.751.971.061.071.381.621.31000
1.731.460.530.530.230.411.041.30.440.450.680.79-0.090.570.80.92
21.7119.817.768.273.957.6116.7919.517.879.0010.7511.60-1.539.7412.8314.06
1.431.060.420.4-0.090.010.751-0.050.220.610.58-0.240.20.40.52
--26.14-59.98-5.44-122.50-107.7810,557.1433.38-105.23-521.15177.63-4.93-141.18-183.19100.5130.98
----------------
----------------
181181181181181183.4191182.6164.8166.3168.7158.3148.91000
----------------
Details

Keystats

Revenue and Growth

The Chemours Revenue and Revenue Growth are pivotal to understanding the company's financial health and operational efficiency. A consistent increase in revenue indicates a company’s ability to effectively market and sell its products or services, while the revenue growth percentage offers insights into the pace at which the company is expanding over the years.

Gross Margin

The Gross Margin is a crucial metric that showcases the percentage of revenue exceeding the cost of goods sold (COGS). A higher gross margin is indicative of a company’s efficiency in controlling its production costs, thereby promising potential profitability and financial stability.

EBIT and EBIT Margin

EBIT (Earnings Before Interest and Taxes) and EBIT Margin offer deep insights into a company’s profitability, excluding the impacts of interest and taxes. Investors often assess these metrics to gauge the operational efficiency and inherent profitability of a business, separate from its financial structure and tax environment.

Income and Growth

Net Income and its subsequent growth are quintessential for investors looking to understand a company’s profitability. Consistent income growth underscores a company’s ability to enhance its profitability over time, reflecting operational efficiency, strategic competitiveness, and financial health.

Shares Outstanding

Shares outstanding refer to the total number of shares a company has issued. It's instrumental in calculating key metrics like Earnings Per Share (EPS) which is pivotal for investors to evaluate a company’s profitability on a per-share basis, offering a more granular view of financial health and valuation.

Interpreting Year to Year Comparison

Comparing yearly data allows investors to identify trends, assess the company’s growth, and anticipate potential future performance. Analyzing how metrics like revenue, income, and margins change year over year can provide valuable insights into the company’s operational efficiency, competitiveness, and overall financial health.

Expectations and Predictions

Investors often juxtapose the current and past financial data with the market’s expectations. This comparison aids in assessing whether the Chemours is performing as anticipated, underperforming or outperforming the market predictions, providing pivotal data for investment decisions.

 
ASSETSCASH BALANCE (B)RECEIVABLES (M)OTHER REC. (M)INVENTORIES (B)OTHER CURRENT LIAB. (M)CURRENT ASSETS (B)TANGIBLE ASSETS (B)LONG-T. INVEST. (M)LONG-T. REC. (M)INTANGIBLE ASSETS (M)GOODWILL (M)OTHER NON-CURRENT ASSETS (M)NON-CURRENT ASSETS (B)TOTAL ASSETS (B)LIABILITIESCOMMON STOCK (M)ADDITIONAL PAID-IN CAPITAL (B)RETAINED EARNINGS (B)OTHER EQUITY (B)UNREAL. GAINS/LOSSES (M)EQUITY (B)LIABILITIES (B)PROVISIONS (M)OTHER SHORT-TERM LIAB. (M)SHORT-TERM DEBTS (M)LONG-TERM DEBT PORTION (M)SHORT-TERM REC. (B)LONG-T. LIAB. (B)DEFERRED TAXES (M)OTHER LIAB. (M)LONG-T. LIABILITIES (B)DEBT (B)TOTAL CAPITAL (B)
20132014201520162017201820192020202120222023
                     
000.370.91.561.20.941.111.451.11.2
762746755740847786600449644509509
67100102657271726276117101
1.061.050.970.770.941.151.080.941.11.41.35
964310679838883787582670
1.981.942.32.553.493.292.782.633.353.213.84
2.973.313.182.783.013.293.853.713.383.413.48
123124136136173160162167169175158
14813712500000000
17111017132821146133
198198166153153153153153102102102
183240383417453437292405547725677
3.644.0243.513.84.074.484.454.214.434.42
5.625.966.36.067.297.367.267.087.557.648.25
                     
00222222222
000.780.790.840.860.860.890.941.021.03
00-0.12-0.110.581.471.251.31.752.171.78
3.213.67-0.54-0.58-0.44-0.56-0.35-0.31-0.36-0.34-0.27
00000000000
3.213.670.130.10.981.761.761.892.332.852.54
1.0310.950.861.011.110.90.821.141.231.13
280187270601321300236308384328971
165207212297304285270293308310330
00000000000
003915151313421252551
1.471.41.471.771.651.711.541.441.861.892.49
003.923.534.13.964.034.013.723.593.99
47742423413220821711836496144
456464553524475457878784837991995
0.930.894.74.194.784.635.024.834.614.645.03
2.42.296.175.966.436.346.566.276.476.537.51
5.625.966.296.067.48.118.328.158.89.3810.06
Details

Balance Sheet

Understanding the Balance Sheet

The balance sheet of Chemours provides a detailed financial snapshot, revealing the company's assets, liabilities, and equity at a specific point in time. Analyzing these components is crucial for investors looking to understand Chemours's financial health and stability.

Assets

Chemours's assets represent everything the company owns or controls that has monetary value. These are categorized into current and non-current assets, offering insights into the company's liquidity and long-term investments.

Liabilities

Liabilities are obligations that Chemours must settle in the future. Analyzing the ratio of liabilities to assets provides insights into the company's financial leverage and risk exposure.

Equity

Equity refers to the residual interest in the assets of Chemours after deducting liabilities. It represents the owners’ claim on the company’s assets and earnings.

Year-to-Year Analysis

Comparing balance sheet figures year-to-year allows investors to identify trends, growth patterns, and potential financial risks, facilitating informed investment decisions.

Interpreting the Data

Detailed analysis of assets, liabilities, and equity can provide investors with comprehensive insights into Chemours's financial standing, aiding in investment evaluations and risk assessments.

 
NET INCOME (B)DEPRECIATION (M)DEFERRED TAXES (M)CHANGES IN WORKING CAPITAL (M)NON-CASH ITEM (M)PAID INTEREST (M)PAID TAXES (M)NET CASH FLOW FROM OPERATING ACTIVITIES (B)CAPITAL EXPENDITURES (M)CASH FLOW FROM INVESTING ACTIVITIES (M)CASH FLOW FROM OTHER INVESTING ACTIVITIES (M)INTEREST INCOME AND EXPENSES (M)NET DEBT CHANGE (B)NET CHANGE IN EQUITY (M)CASH FLOW FROM FINANCING ACTIVITIES (M)CASH FLOW FROM OTHER FINANCING ACTIVITIES (M)TOTAL DIVIDENDS PAID (M)NET CHANGE IN CASH FLOW (M)FREE CASH FLOW (M)SHARE-BASED COMPENSATION (M)
2011201220132014201520162017201820192020202120222023
1.431.060.420.4-0.090.010.751-0.050.220.610.58-0.24
272266261257267284273284311320317291307
4915-14-22-198-1118323-165-120-7720-158
-242-2122-110-27484-466-20613835627-104620
-16535-21230-70316743748-21-442
0000103208208206204208180164223
000053507975857814913154
1.51.390.80.510.180.590.641.140.650.810.820.750.56
-355-432-438-604-519-338-411-498-481-267-277-307-370
-345-429-424-560-497357-370-487-483-234220-284-229
1031444226954111-23349723141
0000000000000
0-0003.48-0.380.47-0.190.09-0.28-0.21-0.080.36
0000011-75-628-31316-150-444-50
-1,151-961-37455687-396353-993-419-449-560-685172
-1,151-960-37455-2,689-4-18-29-30-26-32-814
0000-105-22-22-148-164-164-164-154-149
0000366536654-355-258162446-247503
1,141958360-99-337256228642169540543447186
0000000000000

Chemours stock margins

The Chemours margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Chemours. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Chemours.
  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Chemours's sales revenue. A higher gross margin percentage indicates that the Chemours retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Chemours's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Chemours's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Chemours's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Chemours. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Chemours's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Chemours Margin History

Chemours Gross marginChemours Profit marginChemours EBIT marginChemours Profit margin
2026e21.67 %14.07 %7.95 %
2025e21.67 %12.83 %6.36 %
2024e21.67 %9.75 %3.37 %
202321.67 %-1.53 %-3.95 %
202223.79 %11.6 %8.51 %
202121.77 %10.75 %9.58 %
202021.47 %9 %4.41 %
201919.24 %7.87 %-0.94 %
201829.69 %19.51 %14.99 %
201728.22 %16.79 %12.07 %
201620.43 %7.61 %0.13 %
201516.7 %3.95 %-1.57 %
201421.14 %8.27 %6.22 %
201321.34 %7.76 %6.17 %
201231.92 %19.81 %14.35 %
201132.58 %21.71 %17.95 %

Chemours Stock Sales Revenue, EBIT, Earnings per Share

The Chemours earnings per share therefore indicates how much revenue Chemours has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.
  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Sales per Share
EBIT per share
Earnings per Share
Details

Revenue, EBIT and Earnings per share

Revenue Per Share

Revenue per share represents the total revenue Chemours earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Chemours's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Chemours’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Chemours's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Chemours Revenue, EBIT and net profit per share

DateChemours Sales per ShareChemours EBIT per shareChemours Earnings per Share
2026e43.88 undefined0 undefined3.49 undefined
2025e41.89 undefined0 undefined2.67 undefined
2024e39.41 undefined0 undefined1.33 undefined
202340.47 undefined-0.62 undefined-1.6 undefined
202242.92 undefined4.98 undefined3.65 undefined
202137.61 undefined4.04 undefined3.6 undefined
202029.88 undefined2.69 undefined1.32 undefined
201933.53 undefined2.64 undefined-0.32 undefined
201836.35 undefined7.09 undefined5.45 undefined
201732.37 undefined5.43 undefined3.91 undefined
201629.44 undefined2.24 undefined0.04 undefined
201531.59 undefined1.25 undefined-0.5 undefined
201435.54 undefined2.94 undefined2.21 undefined
201337.9 undefined2.94 undefined2.34 undefined
201240.69 undefined8.06 undefined5.84 undefined
201144.04 undefined9.56 undefined7.91 undefined

Chemours business model

Chemours Co is a US-based chemical company that emerged from the DuPont Performance Chemicals division in 2015. With its headquarters in Wilmington, Delaware, the company employs over 7,000 employees worldwide and has an annual revenue of approximately $6 billion. The company's history dates back to 1802 when Eleuthère Irénée DuPont de Nemours established a powder mill in Wilmington. Over time, DuPont specialized in the production of chemicals for various applications including textiles, electronics, construction, transportation, and food. In 2015, the DuPont Performance Chemicals division was spun off as an independent company under the name Chemours Co. Chemours' business model is based on the development and production of chemicals for various applications including titanium dioxide pigments, fluoroproducts, Nafion membranes, Freon refrigerants, and optical materials. These products are utilized by various industries such as automotive, construction, chemicals, and electronics. The company is divided into three segments: Titanium Technologies, Fluor Technologies, and Chemical Solutions. Chemours' titanium dioxide pigments are produced in the Titanium Technologies segment and are a crucial component in paints, plastics, paper, and other materials. Fluor products, such as refrigerants and fluoropolymer coatings, are manufactured by the Fluor Technologies segment and find application in aerospace, automotive, and semiconductor production. The Chemical Solutions segment produces various chemicals for use in agriculture, oil and gas industry, fuel cell production, and other areas. One well-known product of Chemours is the refrigerant R-134a, marketed under the brand name Freon. This refrigerant was developed in the 1990s as a replacement for the ozone-depleting refrigerant R-12 (Freon 12) and is now widely used in vehicle air conditioning systems and other cooling systems. Another product of Chemours is Nafion membranes, used in fuel cells. These membranes enable the electrochemical reaction that converts hydrogen into electricity and water. Fuel cells are considered an environmentally-friendly energy source for vehicles and buildings. Chemours aims to produce chemicals that are safe, environmentally friendly, and sustainable. The company has developed its own sustainability strategy, which aims to reduce resource consumption, decrease dependence on non-renewable resources, and minimize environmental impact. Chemours has also implemented a comprehensive product safety and quality policy to ensure that all products meet the highest safety and quality standards. Overall, Chemours is a leading provider of chemicals used in a variety of industries. The company is committed to sustainability and product safety and is dedicated to continuously improving its processes and products. Chemours is one of the most popular companies on Eulerpool.com.

Chemours Revenue by Segment

  • 3 years

  • 5 years

  • Max

Details

Revenue by Segment

Overview of Revenue by Segment

The chart visualizes revenues by segments and provides a clear overview of the revenue distribution. Each segment is clearly marked to facilitate comparisons of revenues.

Interpretation and Use

The chart enables quick identification of the highest-revenue segments, which is helpful in strategic decision-making. It supports the analysis of growth potentials and targeted resource allocation.

Investment Strategy

An investment strategy determines how capital is deliberately invested into various asset classes to maximize returns. It is based on risk tolerance, investment objectives, and a long-term plan.

Chemours Revenue by Segment

Segmente201720162015
Fluorochemicals---
Fluoropolymers---
Mining Solutions---
Performance chemicals and intermediates---
Titanium dioxide and other minerals---
Titanium dioxide-2.36 B USD-
Fluoropolymers-1.17 B USD-
Fluorochemicals-1.09 B USD-
Performance chemicals and intermediates-383 M USD-
Mining Solutions-262 M USD-
Sulfur-127 M USD-
Advanced Materials---
Foam, Propellants, and Other---
Performance Chemicals and Intermediates---
Performance Solutions---
Refrigerants---
Titanium Dioxide and Other Minerals---
Fluoropolymers and advanced materials---
Foam, propellants, and other---
Titanium dioxide and other minerals---
Royalty Income---
Titanium dioxide2.96 B USD--
Fluorochemicals1.38 B USD--
Fluoropolymers1.28 B USD--
Performance chemicals and intermediates306 M USD--
Mining Solutions261 M USD--
Fluoroproducts-2.26 B USD2.23 B USD
Titanium technologies2.96 B USD--
Titanium Technologies--2.39 B USD
Chemical Solutions--1.1 B USD
Chemical solutions571 M USD--

Chemours Revenue by Region

  • 3 years

  • 5 years

  • Max

Details

Revenue by Segment

Overview of Revenue by Region

The chart shows revenues by region and provides a clear comparison of regional revenue distribution. Each region is clearly marked to illustrate the differences.

Interpretation and Usage

The diagram helps to identify the regions with the highest revenue and to make targeted decisions for regional expansion or investments. It supports the analysis of market potentials and strategic priorities.

Investment Strategy

An investment strategy focused on regions concentrates on the deliberate capital allocation in different markets to optimally use regional growth opportunities. It takes into account market conditions and regional risk factors.

Chemours Revenue by Segment

DateAsia PacificCanadaEMEAEurope, the Middle East, and AfricaLatin AmericaNorth America
20221.79 B USD--1.31 B USD745 M USD2.95 B USD
20211.83 B USD--1.41 B USD789 M USD2.32 B USD
20201.38 B USD--1.09 B USD585 M USD1.91 B USD
20191.54 B USD--1.16 B USD676 M USD2.14 B USD
20181.72 B USD--1.69 B USD855 M USD2.38 B USD
20151.39 B USD140 M USD977 M USD-777 M USD2.57 B USD

Chemours Eulerpool Fair Value

Details

Fair Value

Understanding Fair Value

The fair value of a stock provides insights into whether the stock is currently undervalued or overvalued. It is calculated based on profit, revenue, or dividends and offers a comprehensive perspective of the stock’s intrinsic value.

Income-Based Fair Value

This is calculated by multiplying the earnings per share by the average P/E ratio of the selected past years for smoothing. If the fair value is higher than the current market price, it suggests that the stock is undervalued.

Example 2022

Fair Value Profit 2022 = Earnings per Share 2022 / Average P/E Ratio 2019 - 2021 (3 Years Smoothing)

Revenue-Based Fair Value

It is derived by multiplying the revenue per share by the average price-to-sales ratio of the selected past years for smoothing. An undervalued stock is identified if the fair value exceeds the ongoing market price.

Example 2022

Fair Value Revenue 2022 = Revenue per Share 2022 / Average PSR 2019 - 2021 (3 Years Smoothing)

Dividend-Based Fair Value

This value is determined by dividing the dividend per share by the average dividend yield of the selected past years for smoothing. A higher fair value than the market price indicates an undervalued stock.

Example 2022

Fair Value Dividend 2022 = Dividend per Share 2022 * Average Dividend Yield 2019 - 2021 (3 Years Smoothing)

Expectations and Forecasts

Future expectations provide potential trajectories for stock prices and aid investors in decision-making. The expected values are forecasted figures of fair value, taking into account the growth or decline trends of profit, revenue, or dividend.

Comparative Analysis

Comparing the fair value based on profit, revenue, and dividend provides a holistic overview of the stock’s financial health. Observing the annual and per-annual variations contributes to understanding the consistency and reliability of stock performance.

Chemours historical P/E ratio, EBIT multiple, and P/S ratio

Chemours shares outstanding

The number of shares was Chemours in 2023 — This indicates how many shares 148.912 M is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.
  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Number of stocks
Details

Revenue, EBIT and Earnings per share

Revenue Per Share

Revenue per share represents the total revenue Chemours earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Chemours's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Chemours’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Chemours's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Chemours dividend history and estimates

In 2023, Chemours paid a dividend amounting to 1 USD. Dividend means that Chemours distributes a portion of its profits to its owners.
  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Dividend
Dividend (Estimate)
Details

Dividend

Dividend Overview

The dividend per year chart for Chemours provides a comprehensive view of the annual dividends distributed to shareholders. Analyze the trend to understand the consistency and growth in dividend payouts over the years.

Interpretation and Use

A consistent or increasing trend in dividends can indicate the company's profitability and financial health. Investors can use this data to identify Chemours’s potential for long-term investment and income generation through dividends.

Investment Strategy

Incorporate the dividend data in evaluating Chemours's overall performance. A thorough analysis, considering other financial aspects, will help in making informed investment decisions for optimal capital growth and income generation.

Chemours Dividend History

DateChemours Dividend
2026e1.33 undefined
2025e1.34 undefined
2024e1.35 undefined
20231 undefined
20221 undefined
20211 undefined
20201 undefined
20191 undefined
20180.84 undefined
20170.12 undefined
20160.12 undefined
20150.61 undefined

Chemours dividend payout ratio

In 2023, Chemours had a payout ratio of 43.64%. The payout ratio indicates the percentage of the company's profits that Chemours distributes as dividends.
  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Payout ratio
Details

Payout ratio

What is Yearly Payout Ratio?

The yearly payout ratio for Chemours represents the proportion of earnings paid out as dividends to shareholders. It is an indicator of the company's financial health and stability, illustrating how much profit is being returned to investors versus being reinvested back into the company.

How to Interpret the Data

A lower payout ratio for Chemours could mean that the company is reinvesting more into its growth, whereas a higher ratio indicates more earnings are being distributed as dividends. Investors seeking regular income might prefer companies with a higher payout ratio, while those looking for growth may opt for companies with a lower ratio.

Using the Data for Investments

Evaluate Chemours's payout ratio in conjunction with other financial metrics and performance indicators. A sustainable payout ratio, coupled with strong financial health, can indicate a reliable dividend payout. However, a very high ratio might suggest the company is not sufficiently reinvesting in its future growth.

Chemours Payout Ratio History

DateChemours Payout ratio
2026e37.08 %
2025e34.66 %
2024e32.94 %
202343.64 %
202227.4 %
202127.78 %
202075.76 %
2019-312.5 %
201815.44 %
20173.08 %
2016300 %
2015-122 %
201443.64 %
201343.64 %
201243.64 %
201143.64 %
Unfortunately, there are currently no price targets and forecasts available for Chemours.

Chemours latest earnings and earnings surprises

DateEPS EstimateEPS ActualQuarterly report
6/30/20240.59 0.38  (-35.51 %)2024 Q2
3/31/20240.19 0.32  (69.94 %)2024 Q1
12/31/20230.26 0.31  (18.59 %)2023 Q4
9/30/20230.71 0.63  (-11.47 %)2023 Q3
6/30/20231.11 1.1  (-0.58 %)2023 Q2
3/31/20230.48 0.98  (103.4 %)2023 Q1
12/31/20220.08 (-100 %)2022 Q4
9/30/20221.07 1.24  (15.36 %)2022 Q3
6/30/20221.48 1.89  (27.89 %)2022 Q2
3/31/20220.95 1.46  (53.81 %)2022 Q1
1
2
3
4

Eulerpool ESG Scorecard© for the Chemours stock

Eulerpool World ESG Rating (EESG©)

80/ 100

🌱 Environment

64

👫 Social

82

🏛️ Governance

93

Environment

Scope 1 - Direct Emissions
5,214,000
Scope 2 - Indirect emissions from purchased energy
1,331,000
Scope 3 - Indirect emissions within the value chain
145,500,000
Total CO₂ emissions
6,545,000
CO₂ reduction strategy
Coal energy
Nuclear power
Animal experiments
Fur & Leather
Pesticides
Palm Oil
Tobacco
Genetically modified organisms
Climate concept
Sustainable forestry
Recycling regulations
Environmentally friendly packaging
Hazardous substances
Fuel consumption and efficiency
Water consumption and efficiency

Social

Percentage of female employees23
Percentage of women in management
Percentage of Asian employees
Share of Asian management
Percentage of Hispanic/Latino employees
Hispano/Latino Management share
Percentage of Black employees
Black Management Share
Percentage of white employees
White Management Share
Adult content
Alcohol
Weapons
Firearms
Gambling
Military contracts
Human rights concept
Privacy concept
Occupational health and safety
Catholic

Governance (Corporate Governance)

Environmental reporting
Stakeholder Engagement
Call Back Policies
Antitrust law

The Eulerpool ESG Scorecard© is the strictly copyrighted intellectual property of Eulerpool Research Systems. Any unauthorized use, imitation, or infringement will be actively pursued and may lead to significant legal consequences. For licenses, collaborations, or usage rights, please contact us directly via our contact form. Contact Form to us.

Chemours shareholders

%
Name
Stocks
Change
Date
9.44899 % Fidelity Management & Research Company LLC14,104,503-577,28912/31/2023
3.18177 % MFS Investment Management4,749,4341,602,27312/31/2023
3.02361 % State Street Global Advisors (US)4,513,348261,08812/31/2023
2.62076 % Marshall Wace LLP3,912,0102,430,82112/31/2023
10.71572 % The Vanguard Group, Inc.15,995,356-136,89012/31/2023
10.18507 % BlackRock Institutional Trust Company, N.A.15,203,250-121,83212/31/2023
1.98869 % JP Morgan Asset Management2,968,512-480,04212/31/2023
1.89790 % Columbia Threadneedle Investments (US)2,833,002252,04212/31/2023
1.77241 % Vaughan Nelson Investment Management, L.P.2,645,6761,263,8753/31/2024
1.70637 % Dimensional Fund Advisors, L.P.2,547,09453,25412/31/2023
1
2
3
4
5
...
10

Chemours Executives and Management Board

Mr. Mark Newman60
Chemours President, Chief Executive Officer, Director (since 2015)
Compensation 7.67 M
Ms. Denise Dignam57
Chemours President - Titanium Technologies and Chemical Solutions
Compensation 1.57 M
Ms. Dawn Farrell63
Chemours Non-Executive Independent Chairman of the Board
Compensation 394,987
Mr. Guillaume Pepy65
Chemours Independent Director
Compensation 321,191
Mr. Curtis Anastasio66
Chemours Independent Director
Compensation 267,487
1
2
3
4

Most common questions regarding Chemours

What values and corporate philosophy does Chemours represent?

Chemours Co represents a strong set of values and corporate philosophy. The company emphasizes integrity, innovation, and sustainability in all its operations. Chemours is committed to delivering exceptional value to its customers, shareholders, and employees while maintaining a focus on responsible and ethical business practices. The company strives to provide innovative solutions that address global challenges and support a more sustainable future. Chemours believes in fostering a diverse and inclusive work environment that encourages collaboration, creativity, and continuous improvement. With its dedication to excellence, Chemours Co aims to be a leader in its industry and contribute positively to society.

In which countries and regions is Chemours primarily present?

Chemours Co is primarily present in various countries and regions around the world. The company has a global presence, with operations and offices in North America, Europe, Asia Pacific, and Latin America. Chemours Co serves customers in industries such as automotive, electronics, chemicals, and many more across these regions. With its strong international footprint, Chemours Co is committed to delivering innovative solutions and products to meet the diverse needs of customers worldwide.

What significant milestones has the company Chemours achieved?

Chemours Co has achieved several significant milestones since its inception. One notable achievement for the company was its successful spin-off from DuPont in 2015, making it an independent entity. Additionally, Chemours has made substantial progress in sustainable manufacturing practices, earning recognition for its commitment to reducing environmental impact. The company has also demonstrated a strong focus on innovation, introducing innovative products and technologies to their portfolio. Furthermore, Chemours has prioritized customer satisfaction by consistently delivering high-quality products and services. Through these achievements, Chemours Co has solidified its position as a leading player in the chemical industry.

What is the history and background of the company Chemours?

Chemours Co, previously a part of DuPont, is a leading global provider of performance chemicals. Founded in 2015, Chemours specializes in delivering innovative solutions across various industries such as automotive, electronics, coatings, and energy. With a strong commitment to sustainable practices, the company focuses on developing products that address societal challenges while minimizing environmental impact. Chemours has a rich heritage and expertise spanning over two centuries, inheriting DuPont's legacy in chemical innovation. As an independent company, Chemours continues to build on its strong foundation, driving growth and providing value to its customers through a diverse portfolio of high-quality products and solutions.

Who are the main competitors of Chemours in the market?

The main competitors of Chemours Co in the market include The Chemours Company, which is a global leader in titanium technologies, fluoroproducts, and chemical solutions. Additionally, other notable competitors in the industry include DuPont, a multinational conglomerate that also specializes in chemicals, materials, and energy, as well as BASF SE, a German chemical company and the largest chemical producer worldwide. These competitors engage in intense market competition, driving innovation and ensuring a diverse range of products and solutions for customers in various industries.

In which industries is Chemours primarily active?

Chemours Co is primarily active in the chemical manufacturing industry. They specialize in the production of performance chemicals used in various sectors such as automotive, electronics, construction, and industrial applications. With a focus on innovative solutions, Chemours Co aims to provide high-quality products that cater to the unique needs of different industries. As a global leader in the chemicals market, Chemours Co continues to drive advancements and contribute to the growth and sustainability of industries worldwide.

What is the business model of Chemours?

The business model of Chemours Co is centered around the production and sale of performance chemicals. Chemours specializes in areas such as titanium technologies, fluoroproducts, and chemical solutions. With a strong focus on innovation and sustainability, the company strives to provide solutions that fulfill market needs while minimizing environmental impact. Chemours leverages its expertise to develop and supply high-quality products across various industries, including automotive, electronics, and construction. By continually refining its products and processes, Chemours aims to create value for its customers and shareholders, maintaining a robust presence in the global chemical industry.

What is the P/E ratio of Chemours 2024?

The Chemours P/E ratio is 14.79.

What is the P/S ratio of Chemours 2024?

The Chemours P/S ratio is 0.5.

What is the AlleAktien quality score of Chemours?

The AlleAktien quality score for Chemours is 2/10.

What is the revenue of Chemours 2024?

The expected Chemours revenue is 5.88 B USD.

How high is the profit of Chemours 2024?

The expected Chemours profit is 198.39 M USD.

What is the business model of Chemours

Chemours Co is a US-American corporation that was separated from the chemical company DuPont in 2015. The company specializes in the production of chemicals and materials and offers its products and services worldwide. The business model of Chemours Co is based on three different business segments: Titanium Technologies, Fluoroproducts, and Chemical Solutions. The Titanium Technologies segment is involved in the manufacturing and distribution of titanium dioxide, which is mainly used in the production of paints, coatings, paper, and plastics. The product range includes standard titanium dioxide, processed titanium dioxide, and specially treated products. The company is one of the largest providers of titanium dioxide worldwide and is often engaged in negotiations with customers, suppliers, and competitors to ensure price and production capacity. The Fluoroproducts segment specializes in the production and distribution of fluorocarbons, including refrigerants, fire extinguishing agents, and chemicals for coatings. The brand "Teflon" plays an important role in this segment, known for its special coatings and non-stick properties. The company also conducts research and development to develop new fluorochemicals as there is strong competitive pressure in this market. The Chemical Solutions segment offers chemicals and equipment for various applications, such as water treatment or the oil and gas industry. The focus is on products used in the production of cooling and lubricating agents, as well as catalysts. Another important aspect of Chemours Co's business model is the production of HFC-23 (used in refrigerators and air conditioners), which emerged based on the reduction commitments from the Kyoto Protocol. Overall, the three business segments of Chemours Co complement each other well and offer a wide range of products. The close collaboration between research and development, sales, and production plays an important role in ensuring that the company's products are always state-of-the-art. Sustainability is also an integral part of Chemours Co's business model. The company is committed to efficient and sustainable production of its products and strives for comprehensive transparency of its processes. Furthermore, the company aims to eliminate the use of perfluorooctanesulfonic acid (PFOS) in some applications of Teflon products. Overall, Chemours Co's business model is focused on long-term and sustainable development, based on access to resources and energy, the discovery of innovations, and strict adherence to ecological and social conditions.

What is the Chemours dividend?

Chemours pays a dividend of 1 USD distributed over payouts per year.

How often does Chemours pay dividends?

The dividend cannot currently be calculated for Chemours or the company does not pay out a dividend.

What is the Chemours ISIN?

The ISIN of Chemours is US1638511089.

What is the Chemours WKN?

The WKN of Chemours is A14RPH.

What is the Chemours ticker?

The ticker of Chemours is CC.

How much dividend does Chemours pay?

Over the past 12 months, Chemours paid a dividend of 1 USD . This corresponds to a dividend yield of about 5.07 %. For the coming 12 months, Chemours is expected to pay a dividend of 1.34 USD.

What is the dividend yield of Chemours?

The current dividend yield of Chemours is 5.07 %.

When does Chemours pay dividends?

Chemours pays a quarterly dividend. This is distributed in the months of December, March, June, September.

How secure is the dividend of Chemours?

Chemours paid dividends every year for the past 12 years.

What is the dividend of Chemours?

For the upcoming 12 months, dividends amounting to 1.34 USD are expected. This corresponds to a dividend yield of 6.8 %.

In which sector is Chemours located?

Chemours is assigned to the 'Commodities' sector.

Wann musste ich die Aktien von Chemours kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Chemours from 9/13/2024 amounting to 0.25 USD, you needed to have the stock in your portfolio before the ex-date on 8/15/2024.

When did Chemours pay the last dividend?

The last dividend was paid out on 9/13/2024.

What was the dividend of Chemours in the year 2023?

In the year 2023, Chemours distributed 1 USD as dividends.

In which currency does Chemours pay out the dividend?

The dividends of Chemours are distributed in USD.

All fundamentals about Chemours

Our stock analysis for Chemours Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Chemours Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.